This session is expected to cover:
- An overview of the CMS Final Rule for OPOs, and the related facts (for example, the metrics, the year of evaluation, the tiers, and timing).
- Implications of the structure, process and outcome of this rule for OPOs, transplant centers, and our system.
- A review of evidence-based, peer reviewed research on these implications and concerns, and possible impacts.
- Additional discussion on patient viewpoints and possible ethical concerns
Speakers:
- Alexandra Glazier, JD, MPH • President and CEO, New England Donor Services, Waltham, MA
- Jesse Schold, PhD, MStat, MEd • Professor, Surgery-Transplant, University of Colorado Anschutz Medical Campus, Aurora, CO
Moderator:
- Kevin Myer, MSHA, FAST • President and Chief Executive Officer, LifeGift, Houston, TX
Discussant:
- Macey Levan, JD, PhD • Associate Professor of Surgery and Population Health, NYU Langone Health, New York, NY
The AST Education Committee would like to thank the AST Donation and Transplantation Optimization Community of Practice (DTO COP) for suggesting this topic as part of the 2025-2026 Timely Topics in Transplantation (T3) webinar series. Learn more about AST's COPs at www.myast.org/cops.
More about Timely Topics in Transplantation (T3) webinars:
- T3 webinars are $25.00 but free for AST members!
- All pre-registrants will have the on-demand recording automatically added to their AST account approximately 1 week after the live session.
- There is no CE available for T3 webinars.
- To learn more about upcoming T3 webinars and view past T3 archives, visit the T3 webinar series page on the myAST website.